Identifying priority outcomes and understanding meaningful delay in disease progression for Alzheimer’s disease across the spectrum
24 Oct 2018
Poster presentation: "Identifying priority outcomes and understanding meaningful delay in disease progression for Alzheimer’s Disease across the spectrum". A. Ly, IMI 10th anniversary scientific symposium, 22-23 October, Brussels (Belgium).
The value of an Expert Advisory Group: Exploration of barriers and facilitators within the ROADMAP international big data project
18 Sep 2018
Poster presentation: "The value of an Expert Advisory Group: Exploration of barriers and facilitators within the ROADMAP international big data project". D. O'Rourke, et al., Guidelines International Network, 12-14 September 2018, Manchester (UK).
Female Caregivers' perspectives on the most important outcomes of Alzheimer's disease/dementia
02 Aug 2018
Oral presentation as part of "Women and Dementia” parallel session Female caregivers’ perspectives on the most important outcomes of Alzheimer’s disease and dementia". C. Tochel, Alzheimer's Disease International Conference, 27 July 2018, Chicago (USA).
Using real-world data to replace missing data for regulatory submissions
21 May 2018
Forum presentation: "Using real-world data to replace missing data for regulatory submissions". H. Kracher, International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting, 21 May 2018, Baltimore MD (USA).
Predictive modelling for secondary prevention of Alzheimer's disease: Ethical concerns and social implications based on targeted, narrative literature review
22 May 2018
Poster presentation: "Predictive modelling for secondary prevention of Alzheimer's disease: Ethical concerns and social implications based on targeted, narrative literature review". Z. Angehrn, et al., International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting, 19-23 May 2018, Baltimore MD (USA).
Real world evidence for investigating AD outcomes: utilising platform resources
18 Apr 2018
Oral presentation: "Real world evidence for investigating AD outcomes: utilising platform resources". N. Vaci, IMI-EMIF Symposium ‘Liberating Evidence from European Health Data – the Achievements and Challenges of a Five-Year IMI Project’, 18 April 2018, Brussels (Belgium).
Modelling the economic value of Alzheimer’s disease interventions: How far have we come, and what next?
14 Feb 2018
On Wednesday 14th February 2018 the Health Economics team from Work Package 5 convened a workshop in Paris entitled “Modelling the economic value of Alzheimer’s disease interventions: How far have we come, and what next”. The following slides are not to be reused in any way without permission.
Symposium: The Future of a Data-Driven Society
25 Jan 2018
Poster presentation: “Real World Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access Platform”. O. Janssen, S. Vos, R. Handels, F. Verhey, P. J. Vissser, Symposium: The Future of a Data-Driven Society, 25 January 2017, Maastricht (the Netherlands).
Ethical issues raised by big data and real-world evidence projects
08 Dec 2017
Oral presentation: "Ethical issues raised by big data and real-world evidence projects". A. Turner, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
The aims of the ROADMAP project
08 Dec 2017
Oral presentation: "The aims of the ROADMAP project". C. Reed, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
A model for Alzheimer’s disease in the prevention setting
04 Nov 2017
Poster presentation: "A model for Alzheimer’s disease in the prevention setting". Hummel Noemi, ISPOR Annual European Congress 2017, 4/11/2017, Glasgow (UK).
Real World Outcomes across the AD spectrum
31 Jul 2017
Poster presentation: “Real World Outcomes across the AD spectrum”. John Gallacher, Alzheimer's Association International Conference (AAIC), 16-20/07/2017, London (UK).
Overcoming ethical issues in sharing real-world evidence in Alzheimer’s disease
21 Jun 2017
Poster presentation: "Overcoming ethical issues in sharing real-world evidence in Alzheimer’s disease: The ROADMAP Project”. J. Krutzinna, Neuroethics Network 2017, 19-21/06/2017, Paris (France).
